Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients

NCT05829317 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Critical Illness
New Onset Atrial Fibrillation

Interventions

DRUG: Magnesium sulfate
DRUG: Placebo

Sponsor

Dr. Stephanie Sibley

Collaborators

[object Object]
[object Object]